A Texas judge has issued a temporary injunction that continues to prevent state officials from enforcing the news Regulations restricting access to hemp-derived products such as THCA combustible flower. Meanwhile, the state Supreme Court in a separate case allows regulators to ban delta-8 THC.
Friday’s ruling by Judge Daniella DeSeta Lyttle follows another judge last month who issued a temporary restraining order on the ban on hemp products. According to the latest order, sales of hemp products can continue until at least July 27.
Decisions a a lawsuit filed by a coalition of hemp industry leaders and advocacy organizations The Department of State Health Services (DSHS) and the Health and Human Services Commission (HHSC) have accused lawmakers of effectively circumventing the law. ban the sale and manufacture of certain hemp consumable products.
Under state law passed by the legislature and governor in 2019, the suit says cannabis products are legal if they contain no more than 0.3 percent delta-9 THC. But regulators at DSHS and HHSC recently approved a “total delta-9 THC” limit using a post-decarboxylation formula that includes tetrahydrocannabinolic acid (THCA) in the calculation.
Texas lawmakers passed legislation to severely restrict hemp products in the 2025 session, but Gov. Greg Abbott (R) vetoed it and did not make it into law.
Lyttle said Friday that the plaintiffs have established “a possible right to relief on the merits of their claims.”
“In the absence of injunction, plaintiffs will suffer immediate and continuing harm to their business operations, legal rights and economic interests,” he said. he wrote. “These damages include disruption of established supply chains, loss of market access, impairment of goodwill and customer relationships, and the risk of significant compliance costs and enforcement consequences under the rules that plaintiffs have proven invalid.”
The hemp industry lawsuit, which also lists Attorney General Ken Paxton (R) as a defendant, also calls into question large increases in business license fees that were approved by regulators. Under the new rules, the cost of a manufacturer’s license increased from $250 to $10,000 per facility, while the retailer registration fee increased from $150 to $5,000 per location.
While the judge who issued a temporary restraining order on the product restrictions last month did not grant a stay on the new fees, Lyttle included them within the scope of his temporary injunction.
“These measures do not impose policy choices of the Legislature; they supersede them,” says the initial complaint filed by plaintiffs Texas Hemp Business Council (THBC) and Hemp Industry & Farmers of America (HIFA). “And they do so against the backdrop of a constitutional legislative process that ran its entire course — from the legislative passage of Senate Bill 3 to the governor’s veto, two failed special sessions — and produced an ambiguous result: no new law. Texas law does not allow agencies to override that result through rulemaking.”
“Texas has long promoted itself as a national leader in economic growth and regulatory stability. It is a state committed to fostering innovation, supporting legitimate businesses, and maintaining a predictable legal environment in which businesses can operate and invest,” he says. “Consistent with that vision, Texas has chosen to authorize and regulate the manufacture, distribution and sale of consumable hemp products (‘CHP’) through a comprehensive statutory framework enacted by the Legislature in 2019.”
“Plaintiffs acknowledge this framework and the State’s interest in ensuring that CHPs are produced and sold in a safe, responsible and lawful manner,” the lawsuit states.
In a state Supreme Court ruling Friday, the justices overturned a lower court’s order that prevented regulators from treating delta-8 THC as a controlled substance.
“The companies that developed these products claim that the legislature opened up the market to them in 2019,” the court’s opinion says. “So when the commissioner sought to clarify that, in fact, the legislature had not clarified the potent levels of delta-8 THC manufactured in consumable hemp products, a group of businesses and consumers asked a court to rewrite the controlled substance schedules for him and the department, especially since the legislature legalized delta-8 THC in 2019 making the commissioner’s actions impossible and ultra vires.”
“The trial court granted that relief by way of a temporary injunction, which was affirmed by the appeals court. We now conclude that the lower courts exceeded their jurisdiction,” the justices said. find. “If the legislature wants to legalize powerful drugs, it has all the tools it needs to do so, and that is inevitable, as we expect such a big change in social policy. The role of the courts is simply to evaluate the state of the law as it stands.”
Separately, Texas officials conditionally approved more new medical marijuana business licenses As part of a law being implemented to significantly expand the state’s cannabis program.
A recent survey showed that Texas voters overwhelmingly support legalizing medical marijuana they still do not know, to a large extent, about the existing program.
in march Texas voters approved a question to legalize marijuana that showed up in the state’s Democratic primary voting.
Another statewide survey released in February found that Texas voters don’t like how state leaders and lawmakers have handled marijuana and THC policy issues. In the poll, many voters (40 percent) said they disapprove of how their elected officials have approached the issue, according to the poll. 29 percent said they approve of how cannabis issues have been handled, while 31 percent said they had no opinion either way.
A separate survey released last year proved this Many Texas voters want the state’s marijuana laws to be “less strict.” And among the issues examined by members of parliament in the last special sessions, the voters said that a proposal to deal with the regulation of hemp was one of the least important.
Meanwhile, the lieutenant governor and speaker of the House recently announced that the state will continue with their own ibogaine research program The drug companies did not submit proposals to meet the requirements and standards for receiving state funds under a recently passed law to begin clinical trials with the psychedelic.
Image courtesy of AnonMoos.